A significant breakthrough in cancer study is occurring with the use of VHH fragments to re-engage dysfunctional p53. This crucial tumor inhibitor protein is frequently lost in several kinds of malignancies, resulting https://bookmarkuse.com/story21751917/nanobodies-revive-tumor-suppressor-p53-the-new-hope-for-tumor-therapy